iShares Mortgage Real Estate ETF

Takeda's ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 1

GuruFocus•25d ago

Why a 10% Yield on REM Still Lost Investors Money: The Mortgage REIT Trap

24/7 Wall Street•25d ago

REM: Improving Fundamentals, But Caution Signs Remain (Upgrade)

Seeking Alpha•2mo ago

These 3 High-Yield ETFs Cost You Thousands If You Hold Them in the Wrong Account

24/7 Wall Street•2mo ago

ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1

GuruFocus•2mo ago